Andrew Rogers

Multiple mutations and bypass mechanisms can contribute to development of acquired resistance to MET inhibitors.

Jie Qi, P. Jänne, J. Engelman, 2011, Cancer research.

Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC.

Luca Toschi, A. Iafrate, P. Jänne, 2010, Cancer cell.